Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir + Sofosbuvir in Pediatric Chronic Hepatitis C
NCT03487848Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Jun 2018; status: terminated.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03487848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03487848.